High expression of mTOR (mammalian target of rapamycin) is associated with better outcome in non-small cell lung cancer

被引:0
|
作者
Anagnostou, Valsamo
Bepler, Gerold
Syrigos, Konstantinos
Tanoue, Lynn
Gettinger, Scott
Homer, Robert
Boffa, Daniel
Detterbeck, Frank
Rimm, David
机构
[1] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA
[2] Univ S Florida, H Lee Moffitt Canc Ctr, Div Thorac Oncol, Tampa, FL 33682 USA
[3] Yale Univ, Sch Med, Dept Internal Med, Sect Med Oncol,Yale Canc Ctr, New Haven, CT 06510 USA
[4] Yale Univ, Sch Med, Sect Pulm & Crit Care Med, New Haven, CT USA
[5] Yale Univ, Sch Med, Dept Surg, New Haven, CT 06510 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
3842
引用
收藏
页数:2
相关论文
共 50 条
  • [41] Complex ALK Fusions Are Associated With Better Prognosis in Advanced Non-Small Cell Lung Cancer
    Kang, Jin
    Zhang, Xu-Chao
    Chen, Hua-Jun
    Zhong, Wen-Zhao
    Xu, Yang
    Su, Jian
    Zhou, Qing
    Tu, Hai-Yan
    Wang, Zhen
    Xu, Chong-Rui
    Yang, Xue-Ning
    Chen, Zhi-Hong
    Wu, Xue
    Zhang, Xian
    Shao, Yang
    Wu, Yi-Long
    Yang, Jin-Ji
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [42] HIGH EXPRESSION OF BAP1 IS BIOMARKER OF BETTER PROGNOSTIC IN ADVANCED NON-SMALL CELL LUNG CANCER PATIENTS
    Zuo, Y.
    Shen, Z.
    ANNALS OF ONCOLOGY, 2012, 23 : 427 - 427
  • [43] Higher Dose of Radiotherapy Better for Outcome of Patients with Locally Advanced Non-Small Cell Lung Cancer
    Vrankar, Martina
    Stanic, Karmen
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1040 - S1040
  • [44] Expression of Fucosyltransferase 8 Is Associated with an Unfavorable Clinical Outcome in Non-Small Cell Lung Cancers
    Honma, Rio
    Kinoshita, Ichiro
    Miyoshi, Eiji
    Tomaru, Utano
    Matsuno, Yoshihiro
    Shimizu, Yasushi
    Takeuchi, Satoshi
    Kobayashi, Yuka
    Kaga, Kichizo
    Taniguchi, Naoyuki
    Dosaka-Akita, Hirotoshi
    ONCOLOGY, 2015, 88 (05) : 298 - 308
  • [45] Neoadjuvant immunotherapy in non-small cell lung cancer: the sooner the better?
    Luis Perez-Gracia, Jose
    Sanmamed, Miguel F.
    Melero, Ignacio
    TRANSLATIONAL LUNG CANCER RESEARCH, 2018, 7 : S356 - S357
  • [46] Is more the better?-cetuximab in non-small cell lung cancer patients
    Moran, Teresa
    TRANSLATIONAL LUNG CANCER RESEARCH, 2018, 7 : S195 - S197
  • [47] High SOX2 Levels Predict Better Outcome in Non-Small Cell Lung Carcinomas
    Velcheti, Vamsidhar
    Schalper, Kurt
    Yao, Xiaopan
    Cheng, Huan
    Kocoglu, Mehmet
    Dhodapkar, Kavita
    Deng, Yanhong
    Gettinger, Scott
    Rimm, David L.
    PLOS ONE, 2013, 8 (04):
  • [48] Expression of long noncoding RNA NBAT1 is associated with the outcome of patients with non-small cell lung cancer
    Wang, Da-Ling
    Yuan, Peng
    Tian, Ji-Yuan
    REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2020, 66 (07): : 898 - 903
  • [49] Concordant expression of the telomerase-associated genes in non-small cell lung cancer
    Hsu, CP
    Miaw, J
    Hsia, JY
    Shai, SE
    Chen, CY
    EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 2003, 29 (07): : 594 - 599
  • [50] Expression of TrkB and BDNF is associated with poor prognosis in non-small cell lung cancer
    Okamura, Kyoko
    Harada, Taishi
    Wang, Shuo
    Ijichi, Kayo
    Furuyama, Kazuto
    Koga, Takaomi
    Okamoto, Tatsuro
    Takayama, Koichi
    Yano, Tokujiro
    Nakanishi, Yoichi
    LUNG CANCER, 2012, 78 (01) : 100 - 106